<unk>  is a somatostatin analogue that is FDA approved for the treatment of acromegaly, severe diarrhea/flushing episodes associated with metastatic carcinoid tumors, profuse watery diarrhea associated with VIP-secreting tumors.   Common adverse reactions include diarrhea, cholelithiasis, abdominal pain, flatulence, back pain, fatigue, headache, abdominal pain, nausea, dizziness.
Octreotide
Lanreotide
Metoclopramide 
Protirelin
Rabeprazole
Omeprazole
Esomeprazole sodium
Pantoprazole 